InvestSMART

Nexsen Limited (ASX: NXN) - Share Price

- Current share price for NXN : $0.235

Nexsen Limited (NXN), an ASX-listed company, is a nano-biotechnology company developing lab-quality diagnostics and sensors that deliver results in minutes - no lab, no delays. The company's modular platform combines advanced materials, biomarker discovery, and machine learning to create scalable, user-friendly tests with unmatched sensitivity and simplicity.

NXN General Information +

ASX Code NXN
Website http://www.nexsen.bio
Industry/Sector Biotechnology
Market Cap ($M) 21
NXN Share Price $0.235
Day High $0.235
Day Low $0.225
Last Close $0.235
NXN Share Price Movement - ( No change )
Prices as at 16:40, 30 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Nexsen Limited (NXN) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Nexsen Limited (NXN) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Nexsen Limited (NXN) price-sensitive announcements

NXN - Quarterly Report - Q4 FY26
Nexsen Limited's Quarterly Activities Report for Q4 FY26 highlights significant progress i
Nexsen Limited (NXN)
29 Jul 2026 | 8:33 AM
NXN - $1.5m non-dilutive ARC funding for manufacturing
Nexsen Limited has secured over $1.5 million in non-dilutive funding to support the scale-
Nexsen Limited (NXN)
25 Jun 2026 | 8:36 AM
NXN - Nexsen secures first hospital partner in Asia
Nexsen Limited has announced a strategic partnership with GHK Hospital Limited, a subsidia
Nexsen Limited (NXN)
13 May 2026 | 8:55 AM
NXN - Nexsen and Universiti Malaya launch joint facility
Nexsen Limited, in collaboration with Universiti Malaya (UM), is launching a new Joint Res
Nexsen Limited (NXN)
4 May 2026 | 8:17 AM

Nexsen Limited (NXN) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Nexsen Limited (NXN)
ORDINARY FULLY PAID
 Health Care $22 Quarterly Report - Q4 FY26 29 Jul 2026 8:33AM $0.270 $0.235 fallen by 12.96%
Nexsen Limited (NXN)
ORDINARY FULLY PAID
 Health Care $22 Launch of Hong Kong facility & pipeline expansion 23 Jul 2026 9:07AM $0.295 $0.235 fallen by 20.34%
Nexsen Limited (NXN)
ORDINARY FULLY PAID
 Health Care $22 Global Healthcare CEO Joins Nexsen Advisory Board 30 Jun 2026 8:43AM $0.240 $0.235 fallen by 2.08%
Nexsen Limited (NXN)
ORDINARY FULLY PAID
 Health Care $22 $1.5m non-dilutive ARC funding for manufacturing 25 Jun 2026 8:36AM $0.225 $0.235 risen by 4.44%
Nexsen Limited (NXN)
ORDINARY FULLY PAID
 Health Care $22 Becoming a substantial holder 15 May 2026 5:11PM $0.225 $0.235 risen by 4.44%
Nexsen Limited (NXN)
ORDINARY FULLY PAID
 Health Care $22 Nexsen secures first hospital partner in Asia 13 May 2026 8:55AM $0.185 $0.235 risen by 27.03%

NXN Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$5.02 -$2.50 0.00% 0.00 0.00 0.00% 0.0%
2024A $0.00 N2 0.00% 0.00 0.00 0.00% 0.0%
2023A -$0.14 -$0.10 0.00% 0.00 0.00 0.00% 0.0%

NXN Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
CSL Limited (CSL) $61,334M 0.1108 -0.1195 0.0168 13.7330 15.5966 15.3396 3.48% 2.85% 2.96%
Clinuvel Pharmaceuticals Limited (CUV) $484M 0.0287 0.0000 0.0000 13.3565 0.0000 0.0000 0.52% 0.00% 0.00%
Mesoblast Limited (MSB) $2,649M 0.0301 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Nexsen Limited (NXN) $22M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Telix Pharmaceuticals Limited (TLX) $4,927M -1.3893 0.0000 -0.1426 0.0000 237.7049 277.2467 0.00% 0.00% 0.00%

NXN Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 -391.70 0.00
Market 0.32 12.80 1.12 0.58
Sector 0.47 34.10 2.36 2.36

NXN Directors

Name Position Start Date
Mr Reece O'Connel Executive Chairman, Executive Director 1 Jan 0001
Mr Mark Anthony Muzzin Managing Director 1 Jan 0001
Mr Grant Anthony Pestell Non-Executive Director 1 Jan 0001
Dr Martina Mariano Non-Executive Director 1 Jan 0001
Professor Shekhar Kumta Non-Executive Director 3 Dec 2025

Nexsen Limited (NXN) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value

See all changes in directors' interest & trades for Nexsen Limited (NXN) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

NXN Management

Name Position
Sonny Didugu Company Secretary

NXN Calendar of Events

Date Event
26 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.